Brief: Pixium Vision gets approval for first-in-human clinical trial of PRIMA
19/10/2017 06:01
Oct 19 (Reuters) - PIXIUM VISION SA PIX.PA
* PIXIUM VISION RECEIVES APPROVAL FOR FIRST-IN-HUMAN
CLINICAL TRIAL OF PRIMA, ITS MINIATURIZED SUB-RETINAL IMPLANT
* RECEIVES AUTHORIZATION FROM ANSM TO START FEASIBILITY
CLINICAL STUDY IN PATIENTS WITH ADVANCED DRY-AMD
Source text for Eikon: urn:newsml:reuters.com:*:nBw6NBYSna
Further company coverage: PIX.PA
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Pixium Vision SA
See all newsBrief: Pixium Vision SA Says Paris Commercial Court Postponed Decision On Takeover Offer Filed On Nov 20, 2023
Brief: Pixium Vision: opening of judicial liquidation proceedings has been postponed to later date
Brief: Pixium Vision Announces Decision About Adoption Of Sale Plan, Opening Of Judicial Liquidation Proceedings Planned For Jan 16, 2024
Brief: Pixium Vision SA Announces Conversion Of Safeguard Proceedings Into Receivership
Brief: Pixium Vision Announces Tender Process For Purpose Of Finding Buyers To Acquire Company's Business Will Be Published Tomorrow